Emboliner ® IDE Study 100 Patient Milestone
The Emboliner "Protect the Head to Head" investigational device exemption (IDE) clinical trial has seen its one hundredth patient enrolled. Emboline, Inc. focuses on reducing stroke and ischemic damage during structural heart procedures such as transcatheter aortic valve replacement (TAVR)....
Latest News
Cardiology
Drug Eluting Stent Market Growth Predicted
The global drug eluting stent (DES) market size is expected to reach USD 13.65 billion by 2030,...
read the full article >Approvals / Clearance
Clinical Studies / Trials
Hemodialysis Access Promise from Polymer Implant
Netherlands and US-based medtech company Xeltis tells us about its first-in-human (FIH) vascular...
read the full article >